Crescentic glomerulonephritis with antimyeloperoxidase antibodies developing during the course of IgA nephropathy in a patient with rheumatoid arthritis

M Uchiyama; T Akahoshi; T Matsui; H Watabe; K Koredo; S Tanaka; T Matsuo; H Tatsumi; K Kamata; Y Kobayashi; H Kondo

doi:10.3109/s101650170049

Crescentic glomerulonephritis with antimyeloperoxidase antibodies developing during the course of IgA nephropathy in a patient with rheumatoid arthritis

Mod Rheumatol. 2001 Mar;11(1):76-9. doi: 10.3109/s101650170049.

Authors

M Uchiyama¹, T Akahoshi, T Matsui, H Watabe, K Koredo, S Tanaka, T Matsuo, H Tatsumi, K Kamata, Y Kobayashi, H Kondo

Affiliation

¹ Department of Internal Medicine, Kitasato University School of Medicine , 1-15-1 Kitasato, Sagamihara 228-8555 , Japan.

PMID: 24387026
DOI: 10.3109/s101650170049

Abstract

Abstract Glomerulonephritis, such as membranous nephropathy, IgA nephropathy, and p-antineutrophil cytoplasmic autoantibody (ANCA)-related crescentic glomerulonephritis, has been shown to occur in rheumatoid arthritis (RA). However, the occurrence of two types of glomerulonephritis in a patient with RA is rarely observed. Here, we describe a patient with RA who developed crescentic glomerulonephritis with antimyeloperoxidase (MPO) antibodies during the course of IgA nephropathy. This case indicates that crescentic glomerulonephritis and IgA nephropathy may occur together in association with p-ANCA in RA.